期刊文献+

泊尼松治疗24例丛集性头痛的疗效观察 被引量:5

Therapeutic effect of predisone in the treatment of 24 patients with episodic cluster headache
原文传递
导出
摘要 目的探索泊尼松治疗丛集性头痛的有效性。方法采用前瞻性的方法,给予丛集性头痛患者口服泊尼松40mg/d,连服10 d,然后每周减10 mg,与既往发作的丛集期比较,观察患者的丛集发作时间、发作频率、疼痛程度。结果经泊尼松治疗后丛集性发作时间较前有缩短[(2.88±1.23) d vs (28.88±11.96)d],有显著性差异(P=0.000);头痛发作频率较前有减少[(1.04±2.42)d vs (15.50± 11.24)d],有显著性差异(P=0.000);头痛的程度较前减轻[(0.83±1.74)d vs (9.83±0.48)d],有显著性差异 (P=0.000)。结论泊尼松能非常有效治疗丛集性头痛发作。 Objective To study the effectiveness of predisone in preventing cluster headache. Methods 24 patients with episodic cluster headache were treated with prednisone (40 mg/day, orally) for 10 consecutive days, followed by gradual decrease of the dosage (10 mg/week). Headache parameters (duration of active phase, onset frequency and degree of pains) at the active phases treated with prednisone were compared with those of previous active phases in the same patients treated with other prophylactic medications. Results Compared with previous treatment by predisone, the duration of active phases, onset frequency and degree of pains were significantly decreased (2.88 ± 1.23) d vs (28.88 ± 11.96) d, P= 0.000;(1.04±2.42 ) d vs (15.50±11.24) d, P=0.000; (0.83±1.74) d vs (9.83±0.48) d, P=0.000, respectively). Conclusion Prednisone is effective in reducing duration of cluster, frequency and severity of headache in patients with episodic cluster headache.
出处 《中华神经医学杂志》 CAS CSCD 2006年第5期527-528,共2页 Chinese Journal of Neuromedicine
关键词 丛集性头痛 泊尼松 Cluster headache Prednisone
  • 相关文献

参考文献10

  • 1龙洁,主译.Alarn M.Rapoport,MD[美],Fred D,Sheftell MD[美],主编.最新临床头痛治疗学[M].北京:中国协和医科大学出版社,2003.192-193.
  • 2Pringsheim T.Cluster headache:evidence for a disorder of circadian rhythm and hypothalamic function[J].Can J Neurol Sci,2002,29(1):33-40.
  • 3Antonaci F,Costa A,Candeloro E,et al.Single high-dose steroid treatment in episodic cluster headache[J].Cephalalgia,2005,25(4):290-295.
  • 4Mir P,Alberca R,Navarro A,et al.Prophylactic treatment of episodic cluster headache with intravenous bolus of methylprednisolone[J].Neurol Sci,2003,24(5):318-321.
  • 5Figuerola ML,Levin G,Leston J,et al.Opioid and sympathetic nervous system activity in cluster headache under verapamil or prednisone treatment[J].Headache,1994,34(5):257-260.
  • 6Elenkov IJ,Chrousos GP.Stress hormones,proinflammatory and antiinflammatory cytokines,and autoimmunity[J].Ann N Y Acad Sci,2002,966(4):290-303.
  • 7Balsalobre A,Brown SA,Marcacci L,et al.Resetting of circadian time in peripheral tissues by glucocorticoid signaling[J].Science,2000,289(5488):2344-2347.
  • 8Edvinsson L,Goadsby PJ.Neuropeptides in migraine and cluster headache[J].Cephalalgia,1994,14(5):320-327.
  • 9Larsen PJ,Vrang N,Moller M,et al.The diurnal expression of genes encoding vasopressin and vasoactive intestinal peptide within the rat suprachiasmatic nucleus is influenced by circulating glucocorticoids[J].Brain Res Mol Brain Res,1994,27(2):342-346.
  • 10O' Connor TM,O' Connell J,O'Brien DI,et al.The role of substance P in inflammatory disease[J].J Cell Physiol,2004,201(2):167-180.

共引文献2

同被引文献34

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部